1. Home
  2. CNTA vs PLYA Comparison

CNTA vs PLYA Comparison

Compare CNTA & PLYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTA
  • PLYA
  • Stock Information
  • Founded
  • CNTA 2020
  • PLYA 2006
  • Country
  • CNTA United Kingdom
  • PLYA Netherlands
  • Employees
  • CNTA N/A
  • PLYA N/A
  • Industry
  • CNTA Biotechnology: Pharmaceutical Preparations
  • PLYA Hotels/Resorts
  • Sector
  • CNTA Health Care
  • PLYA Consumer Discretionary
  • Exchange
  • CNTA Nasdaq
  • PLYA Nasdaq
  • Market Cap
  • CNTA 1.6B
  • PLYA 1.7B
  • IPO Year
  • CNTA 2021
  • PLYA N/A
  • Fundamental
  • Price
  • CNTA $13.68
  • PLYA $13.46
  • Analyst Decision
  • CNTA Strong Buy
  • PLYA Hold
  • Analyst Count
  • CNTA 11
  • PLYA 5
  • Target Price
  • CNTA $27.00
  • PLYA $12.00
  • AVG Volume (30 Days)
  • CNTA 730.3K
  • PLYA 1.1M
  • Earning Date
  • CNTA 05-14-2025
  • PLYA 05-05-2025
  • Dividend Yield
  • CNTA N/A
  • PLYA N/A
  • EPS Growth
  • CNTA N/A
  • PLYA 8.44
  • EPS
  • CNTA N/A
  • PLYA 0.49
  • Revenue
  • CNTA $15,000,000.00
  • PLYA $896,462,000.00
  • Revenue This Year
  • CNTA N/A
  • PLYA N/A
  • Revenue Next Year
  • CNTA N/A
  • PLYA $7.37
  • P/E Ratio
  • CNTA N/A
  • PLYA $27.68
  • Revenue Growth
  • CNTA 118.88
  • PLYA N/A
  • 52 Week Low
  • CNTA $7.90
  • PLYA $6.95
  • 52 Week High
  • CNTA $19.09
  • PLYA $13.46
  • Technical
  • Relative Strength Index (RSI)
  • CNTA 56.37
  • PLYA 65.72
  • Support Level
  • CNTA $12.11
  • PLYA $13.43
  • Resistance Level
  • CNTA $13.23
  • PLYA $13.45
  • Average True Range (ATR)
  • CNTA 0.73
  • PLYA 0.02
  • MACD
  • CNTA 0.12
  • PLYA -0.00
  • Stochastic Oscillator
  • CNTA 98.13
  • PLYA 100.00

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

About PLYA Playa Hotels & Resorts N.V.

Playa Hotels & Resorts NV acts as an owner, operator, and developer of all-inclusive resorts in prime beachfront locations in popular vacation destinations in Mexico and the Caribbean. The company has four reportable segments by geography, including the Yucatan Peninsula, Pacific Coast, Dominican Republic, and Jamaica. It generates a majority of its revenue from the Yucatan Peninsula segment. Its brand profile consists of Hyatt Ziva, Hyatt Zilara, Hilton, Jewel Resorts, and others.

Share on Social Networks: